Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
MeVis Medical Solutions cuts full-year forecast after half-year results
MeVis Medical Solutions reports first-half (1 Oct 2025–31 Mar 2026) revenues of TEUR 7,861 (prev. TEUR 8,438) and an EBIT of TEUR 160 (prev. TEUR 1,853). The decline is due to lower sales, higher personnel costs following the integration of the former joint venture MeVis Breast Care, weak demand in mammography and delays in lung-cancer screening in Germany. The outlook for 2025/2026 is adjusted to revenue of EUR 16.5m–17.0m and an expected EBIT of EUR 0.5m–1.0m (previous: revenue EUR 17.5–18.0m; EBIT EUR 1.0–1.5m). » More on de.investing.com
MeVis Medical Solutions AG revises 2024/2025 forecast downward
MeVis Medical Solutions AG lowers its forecast for the 2024/2025 financial year and now expects revenue of EUR 16.5–17.0 million (previously EUR 17.0–17.5 million) and EBIT of EUR 3.0–3.5 million (previously EUR 3.5–4.0 million). The cause is a license sale that fell short of expectations and cannot be offset by maintenance and other revenues. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | March 2026 | YoY |
|---|---|---|
| Revenue | 3.93m | - |
| Gross profit | 599.77k | - |
| Net profit | 311k | - |
| EBITDA | 45.49k | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €36.76m |
Number of shares | 1.82m |
52-week high/low | €26.80 - €19.90 |
Dividend yield | 4.70% |
Dividends TTM | €0.95 |
Beta | -0.04 |
P/E ratio | 26.58 |
PEG ratio | -0.39 |
P/B ratio | 2.06 |
P/S ratio | 2.37 |
Company profile
MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.
| Name | MeVis Medical Solutions AG |
| CEO | Marcus Kirchhoff |
| Headquarters | Bremen,
be Germany |
| Website | |
| Sector | Information Technology |
| Industry | Software |
| IPO | 16/11/2007 |
| Employees | 127 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | M3V.DE |
Frankfurt | M3V.F |
Düsseldorf | M3V.DU |
London | 0HI7.L |
München | M3V.MU |
Hamburg | M3V.HM |